APO Research
Talk to an analyst

APO RESEARCH · REPORT

α4β7 Integrin Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global α4β7 Integrin Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025170 pages

Choose your research edition.

Industry Researchα4β7 Integrin Antagonists Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal α4β7 Integrin Antagonists Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal α4β7 Integrin Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal α4β7 Integrin Antagonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal α4β7 Integrin Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global α4β7 Integrin Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of α4β7 Integrin Antagonists include Biogen, Novartis, Sandoz and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global α4β7 Integrin Antagonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of α4β7 Integrin Antagonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents α4β7 Integrin Antagonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the α4β7 Integrin Antagonists market size, projected growth trends, production technologies, key applications, and end-use industries.

α4β7 Integrin Antagonists Segment by Company

Biogen

Novartis

Sandoz

Takeda

α4β7 Integrin Antagonists Segment by Type

Natalizumub

Vedolizumab

α4β7 Integrin Antagonists Segment by Application

Inflammatory Bowel Disease (IBD)

Multiple Sclerosis (MS)

Other

α4β7 Integrin Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global α4β7 Integrin Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of α4β7 Integrin Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of α4β7 Integrin Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the α4β7 Integrin Antagonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of α4β7 Integrin Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of α4β7 Integrin Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of α4β7 Integrin Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. α4β7 Integrin Antagonists Industry Trends Table 2. α4β7 Integrin Antagonists Industry Drivers Table 3. α4β7 Integrin Antagonists Industry Opportunities and Challenges Table 4. α4β7 Integrin Antagonists Industry Restraints Table 5. Global α4β7 Integrin Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global α4β7 Integrin Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global α4β7 Integrin Antagonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global α4β7 Integrin Antagonists Sales Market Share by Manufacturers Table 9. Global α4β7 Integrin Antagonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global α4β7 Integrin Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global α4β7 Integrin Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global α4β7 Integrin Antagonists Manufacturers, Product Type & Application Table 13. Global α4β7 Integrin Antagonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global α4β7 Integrin Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Natalizumub Table 17. Major Manufacturers of Vedolizumab Table 18. Global α4β7 Integrin Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 20. Global α4β7 Integrin Antagonists Sales by Type (2027-2032) & (K Units) Table 21. Global α4β7 Integrin Antagonists Sales Market Share by Type (2021-2026) Table 22. Global α4β7 Integrin Antagonists Sales Market Share by Type (2027-2032) Table 23. Global α4β7 Integrin Antagonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global α4β7 Integrin Antagonists Revenue by Type (2021-2026) & (K Units) Table 25. Global α4β7 Integrin Antagonists Revenue by Type (2027-2032) & (K Units) Table 26. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2021-2026) Table 27. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Inflammatory Bowel Disease (IBD) Table 29. Major Manufacturers of Multiple Sclerosis (MS) Table 30. Major Manufacturers of Other Table 31. Global α4β7 Integrin Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 33. Global α4β7 Integrin Antagonists Sales by Application (2027-2032) & (K Units) Table 34. Global α4β7 Integrin Antagonists Sales Market Share by Application (2021-2026) Table 35. Global α4β7 Integrin Antagonists Sales Market Share by Application (2027-2032) Table 36. Global α4β7 Integrin Antagonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global α4β7 Integrin Antagonists Revenue by Application (2021-2026) & (K Units) Table 38. Global α4β7 Integrin Antagonists Revenue by Application (2027-2032) & (K Units) Table 39. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2021-2026) Table 40. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2027-2032) Table 41. Global α4β7 Integrin Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global α4β7 Integrin Antagonists Sales by Region (2021-2026) & (K Units) Table 43. Global α4β7 Integrin Antagonists Sales Market Share by Region (2021-2026) Table 44. Global α4β7 Integrin Antagonists Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global α4β7 Integrin Antagonists Sales Forecasted Market Share by Region (2027-2032) Table 46. North America α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 48. North America α4β7 Integrin Antagonists Sales by Country (2027-2032) & (K Units) Table 49. Europe α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 51. Europe α4β7 Integrin Antagonists Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific α4β7 Integrin Antagonists Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2027-2032) & (K Units) Table 58. Global α4β7 Integrin Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global α4β7 Integrin Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 60. Global α4β7 Integrin Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 61. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2021-2026) Table 62. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2027-2032) Table 63. Biogen Company Information Table 64. Biogen Business Overview Table 65. Biogen α4β7 Integrin Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biogen α4β7 Integrin Antagonists Product Portfolio Table 67. Biogen Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis α4β7 Integrin Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis α4β7 Integrin Antagonists Product Portfolio Table 72. Novartis Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz α4β7 Integrin Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sandoz α4β7 Integrin Antagonists Product Portfolio Table 77. Sandoz Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda α4β7 Integrin Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Takeda α4β7 Integrin Antagonists Product Portfolio Table 82. Takeda Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. α4β7 Integrin Antagonists Distributors List Table 86. α4β7 Integrin Antagonists Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. α4β7 Integrin Antagonists Product Image Figure 2. Global α4β7 Integrin Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global α4β7 Integrin Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global α4β7 Integrin Antagonists Sales (2021-2032) & (K Units) Figure 5. Global α4β7 Integrin Antagonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 α4β7 Integrin Antagonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Natalizumub Image Figure 9. Vedolizumab Image Figure 10. Global α4β7 Integrin Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global α4β7 Integrin Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global α4β7 Integrin Antagonists Sales Market Share by Type (2021-2032) Figure 13. Global α4β7 Integrin Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global α4β7 Integrin Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2021-2032) Figure 16. Inflammatory Bowel Disease (IBD) Image Figure 17. Multiple Sclerosis (MS) Image Figure 18. Other Image Figure 19. Global α4β7 Integrin Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global α4β7 Integrin Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global α4β7 Integrin Antagonists Sales Market Share by Application (2021-2032) Figure 22. Global α4β7 Integrin Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global α4β7 Integrin Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2021-2032) Figure 25. North America α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America α4β7 Integrin Antagonists Sales Market Share by Country (2021-2032) Figure 27. U.S. α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe α4β7 Integrin Antagonists Sales Market Share by Country (2021-2032) Figure 32. Germany α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific α4β7 Integrin Antagonists Sales Market Share by Country (2021-2032) Figure 39. China α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa α4β7 Integrin Antagonists Sales Market Share by Country (2021-2032) Figure 47. Brazil α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile α4β7 Integrin Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global α4β7 Integrin Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global α4β7 Integrin Antagonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America α4β7 Integrin Antagonists Revenue (2021-2032) & (US$ Million) Figure 58. North America α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe α4β7 Integrin Antagonists Revenue (2021-2032) & (US$ Million) Figure 60. Europe α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific α4β7 Integrin Antagonists Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa α4β7 Integrin Antagonists Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. α4β7 Integrin Antagonists Value Chain Figure 66. Manufacturing Cost Structure Figure 67. α4β7 Integrin Antagonists Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Natalizumub
  • Vedolizumab
Applications
  • Inflammatory Bowel Disease (IBD)
  • Multiple Sclerosis (MS)
  • Other
Companies covered
  • Biogen
  • Novartis
  • Sandoz
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global α4β7 Integrin Antagonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global α4β7 Integrin Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global α4β7 Integrin Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global α4β7 Integrin Antagonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global α4β7 Integrin Antagonists Market Dynamics
  1. 2.1 α4β7 Integrin Antagonists Industry Trends
  2. 2.2 α4β7 Integrin Antagonists Industry Drivers
  3. 2.3 α4β7 Integrin Antagonists Industry Opportunities and Challenges
  4. 2.4 α4β7 Integrin Antagonists Industry Restraints
3 α4β7 Integrin Antagonists Market by Manufacturers
  1. 3.1 Global α4β7 Integrin Antagonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global α4β7 Integrin Antagonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global α4β7 Integrin Antagonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global α4β7 Integrin Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global α4β7 Integrin Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global α4β7 Integrin Antagonists Manufacturers, Product Type & Application
  7. 3.7 Global α4β7 Integrin Antagonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global α4β7 Integrin Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 α4β7 Integrin Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 α4β7 Integrin Antagonists Tier 1, Tier 2, and Tier 3
4 α4β7 Integrin Antagonists Market by Type
  1. 4.1 α4β7 Integrin Antagonists Type Introduction
  2. 4.1.1 Natalizumub
  3. 4.1.2 Vedolizumab
  4. 4.2 Global α4β7 Integrin Antagonists Sales by Type
  5. 4.2.1 Global α4β7 Integrin Antagonists Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global α4β7 Integrin Antagonists Sales by Type (2021-2032)
  7. 4.2.3 Global α4β7 Integrin Antagonists Sales Market Share by Type (2021-2032)
  8. 4.3 Global α4β7 Integrin Antagonists Revenue by Type
  9. 4.3.1 Global α4β7 Integrin Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global α4β7 Integrin Antagonists Revenue by Type (2021-2032)
  11. 4.3.3 Global α4β7 Integrin Antagonists Revenue Market Share by Type (2021-2032)
5 α4β7 Integrin Antagonists Market by Application
  1. 5.1 α4β7 Integrin Antagonists Application Introduction
  2. 5.1.1 Inflammatory Bowel Disease (IBD)
  3. 5.1.2 Multiple Sclerosis (MS)
  4. 5.1.3 Other
  5. 5.2 Global α4β7 Integrin Antagonists Sales by Application
  6. 5.2.1 Global α4β7 Integrin Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global α4β7 Integrin Antagonists Sales by Application (2021-2032)
  8. 5.2.3 Global α4β7 Integrin Antagonists Sales Market Share by Application (2021-2032)
  9. 5.3 Global α4β7 Integrin Antagonists Revenue by Application
  10. 5.3.1 Global α4β7 Integrin Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global α4β7 Integrin Antagonists Revenue by Application (2021-2032)
  12. 5.3.3 Global α4β7 Integrin Antagonists Revenue Market Share by Application (2021-2032)
6 Global α4β7 Integrin Antagonists Sales by Region
  1. 6.1 Global α4β7 Integrin Antagonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global α4β7 Integrin Antagonists Sales by Region (2021-2032)
  3. 6.2.1 Global α4β7 Integrin Antagonists Sales by Region (2021-2026)
  4. 6.2.2 Global α4β7 Integrin Antagonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America α4β7 Integrin Antagonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe α4β7 Integrin Antagonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific α4β7 Integrin Antagonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa α4β7 Integrin Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global α4β7 Integrin Antagonists Revenue by Region
  1. 7.1 Global α4β7 Integrin Antagonists Revenue by Region
  2. 7.1.1 Global α4β7 Integrin Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global α4β7 Integrin Antagonists Revenue by Region (2021-2026)
  4. 7.1.3 Global α4β7 Integrin Antagonists Revenue by Region (2027-2032)
  5. 7.1.4 Global α4β7 Integrin Antagonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America α4β7 Integrin Antagonists Revenue (2021-2032)
  8. 7.2.2 North America α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe α4β7 Integrin Antagonists Revenue (2021-2032)
  11. 7.3.2 Europe α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific α4β7 Integrin Antagonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa α4β7 Integrin Antagonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa α4β7 Integrin Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen
  2. 8.1.1 Biogen Company Information
  3. 8.1.2 Biogen Business Overview
  4. 8.1.3 Biogen α4β7 Integrin Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogen α4β7 Integrin Antagonists Product Portfolio
  6. 8.1.5 Biogen Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis α4β7 Integrin Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis α4β7 Integrin Antagonists Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz α4β7 Integrin Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz α4β7 Integrin Antagonists Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Takeda
  20. 8.4.1 Takeda Company Information
  21. 8.4.2 Takeda Business Overview
  22. 8.4.3 Takeda α4β7 Integrin Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takeda α4β7 Integrin Antagonists Product Portfolio
  24. 8.4.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 α4β7 Integrin Antagonists Value Chain Analysis
  2. 9.1.1 α4β7 Integrin Antagonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 α4β7 Integrin Antagonists Production Mode & Process
  6. 9.2 α4β7 Integrin Antagonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 α4β7 Integrin Antagonists Distributors
  9. 9.2.3 α4β7 Integrin Antagonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst